about
Novel epigallocatechin-3-gallate (EGCG) derivative as a new therapeutic strategy for reducing neuropathic pain after chronic constriction nerve injury in miceEffect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgiaAntidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain reliefAssessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients.Neuropathic pain: a personal case reflection on a critical incident.Paroxetine alleviates rat limb post-ischemia induced allodynia through GRK2 upregulation in superior cervical ganglia.Effect of subcutaneous treatment with human umbilical cord blood-derived multipotent stem cells on peripheral neuropathic pain in rats.μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia.Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocksNeuropathic pain: strategies in drug discovery and treatment.Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design.Paroxetine attenuates the development and existing pain in a rat model of neurophatic pain.Interaction of morphine and selective serotonin receptor inhibitors in rats experiencing inflammatory pain.Postherpetic neuralgia, diabetic neuropathy, and trigeminal neuralgia - Chronic peripheral neuropathic pain in 58,480 rural Italian primary care patients.Analgesic Properties of Opioid/NK1 Multitarget Ligands with Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor.Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice.The influence of excipients on physical and pharmaceutical properties of oral lyophilisates containing a pregabalin-acetaminophen combination.
P2860
Q28546011-8461C3A1-205B-4D4B-A0A6-8DCC05F87ECEQ33715079-3C68667A-139C-4881-9B11-B6FB09657753Q34606838-A670C0D6-1142-424D-A10B-5DF891CB887FQ34900858-0B0A2798-7410-4C5A-9A0E-415AA9DFF8FDQ35245083-FD0B5811-88DD-45CA-B9E5-47287BA5568EQ35479887-B80D7D9A-E410-4D0B-98BA-3DD24934C9D1Q37689496-FC61758F-3D1B-4B31-B1BD-B8668E5BCE22Q37721910-11F1E265-D8A8-4538-A4B5-0AD16935EB4DQ37820983-BFB5F427-384A-4769-B9F7-33BBE2E8F0C2Q38011182-73EE86D6-4248-4604-85C7-FE447C6F3D70Q38089846-E8EC2CD2-4B0C-4433-8455-4651BE8D531FQ39956407-A23CFAC2-19E8-4631-81F9-9CB02A90CB79Q41976253-9FA72388-E68D-4BE3-A11B-FFA139C50D2CQ42017209-DA7205F1-7EF8-4920-A98A-47AC94FA9427Q42276128-E60B374A-77DA-49B9-A380-F56778F9AAA7Q42380129-9ED0C721-B57E-43E4-A198-FE32D3781293Q48392103-84B677EA-2A9B-4F70-B766-FC8721674916Q50279096-72FF011F-AD43-4E9A-AD1A-9F38B1F7BC3CQ52705392-3453CF15-EF0B-4A73-8DE8-6036A757B9F5
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pharmacotherapy for neuropathic pain.
@ast
Pharmacotherapy for neuropathic pain.
@en
type
label
Pharmacotherapy for neuropathic pain.
@ast
Pharmacotherapy for neuropathic pain.
@en
prefLabel
Pharmacotherapy for neuropathic pain.
@ast
Pharmacotherapy for neuropathic pain.
@en
P2860
P1433
P1476
Pharmacotherapy for neuropathic pain.
@en
P2093
Kenneth C Jackson
P2860
P356
10.1111/J.1533-2500.2006.00055.X
P577
2006-03-01T00:00:00Z